India to United States: Repaglinide Export Trade Route
India has recorded 126 verified shipments of Repaglinide exported to United States, representing a combined trade value of $3.5M USD. This corridor is served by 3 active Indian exporters, with an average shipment value of $27.4K USD. The leading Indian exporter is AUROBINDO PHARMA LTD, which accounts for 55% of total export value with 76 shipments worth $1.9M USD. On the buying side, RISING PHARMA HOLDINGS INC is the largest importer in United States with $463.1K USD in purchases. The top 3 suppliers — AUROBINDO PHARMA LTD, AUROBINDO PHARMA LIMITED, MACLEODS PHARMACEUTICALS LTD — together control 100% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to United States Repaglinide corridor is one of India's established pharmaceutical export routes, with 126 shipments documented worth a combined $3.5M USD. The route is dominated by AUROBINDO PHARMA LTD, which alone accounts for roughly 55% of all export value, reflecting the consolidated nature of India's repaglinide manufacturing sector.
Across 3 active suppliers, the average shipment value stands at $27.4K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 74% of all shipments, consistent with repaglinide's non-urgent bulk-order profile.
Shipment activity peaks during January–March, with an average transit time of 15 days port-to-port. The route has recorded an annual growth rate of 17.6%, placing it at rank #8 among India's top repaglinide export destinations globally.
On the import side, key buyers of Indian repaglinide in United States include RISING PHARMA HOLDINGS INC, AUROLOGISTICS LLC(AUROBINDO PHARMA, AUROLOGISTICS LLC AUROBINDO PHARM and 16 others. RISING PHARMA HOLDINGS INC is the single largest importer with 16 shipments valued at $463.1K USD.
Route Characteristics
- Average transit15 days
- Peak seasonQ1
- Primary modeSea freight
- Top portHYDERABAD ICD
Market Position
- Global rank#8
- Annual growth+17.6%
- Demand growth+17.0%
- Regulatory ease77/100
Top 10 Indian Repaglinide Exporters to United States
Showing top 10 of 3 Indian suppliers exporting Repaglinide to United States, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | AUROBINDO PHARMA LTD Avg $25.1K per shipment | 76 | $1.9M | 55.2% |
| 2 | AUROBINDO PHARMA LIMITED Avg $38.8K per shipment | 33 | $1.3M | 37.1% |
| 3 | MACLEODS PHARMACEUTICALS LTD Avg $15.7K per shipment | 17 | $267.7K | 7.8% |
This table shows the top 10 of 3 Indian companies exporting repaglinide to United States, ranked by total trade value. The listed exporters are: AUROBINDO PHARMA LTD, AUROBINDO PHARMA LIMITED, MACLEODS PHARMACEUTICALS LTD. AUROBINDO PHARMA LTD is the dominant supplier with 76 shipments worth $1.9M USD, giving it a 55% market share.
Top 10 Repaglinide Importers in United States
Showing top 10 of 19 known buyers in United States receiving Repaglinide shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian repaglinide in United States include RISING PHARMA HOLDINGS INC, AUROLOGISTICS LLC(AUROBINDO PHARMA, AUROLOGISTICS LLC AUROBINDO PHARM, AUROLOGISTICS LLC (AUROBINDO PHARMA, RISING PHARMA HOLDINGS, INC., among 19 total buyers. The largest importer is RISING PHARMA HOLDINGS INC, accounting for $463.1K USD across 16 shipments — representing 13% of all repaglinide imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | RISING PHARMA HOLDINGS INC | 16 | $463.1K | 13.4% |
| 2 | AUROLOGISTICS LLC(AUROBINDO PHARMA | 14 | $461.1K | 13.4% |
| 3 | AUROLOGISTICS LLC AUROBINDO PHARM | 8 | $443.2K | 12.8% |
| 4 | AUROLOGISTICS LLC (AUROBINDO PHARMA | 13 | $440.7K | 12.8% |
| 5 | RISING PHARMA HOLDINGS, INC. | 25 | $368.6K | 10.7% |
| 6 | AUROLOGISTICS LLC | 4 | $261.5K | 7.6% |
| 7 | RISING PHARMA HOLDINGS, INC. ,. | 7 | $186.3K | 5.4% |
| 8 | AUROLOGISTICS LLC, (AUROBINDO PHARM | 3 | $168.0K | 4.9% |
| 9 | MACLEODS PHARMA USA INC | 6 | $118.1K | 3.4% |
| 10 | AUROLOGISTICS LLC, | 2 | $103.1K | 3.0% |
Showing top 10 of 19 Repaglinide importers in United States on this route.
Top 10 Repaglinide Formulations Imported by United States
Showing top 10 of 76 product formulations shipped on the India to United States Repaglinide route, ranked by trade value
United States imports a wide range of repaglinide formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — REPAGLINIDE TABLETS 1 MG (REPAGLINIDE TABLETS USP 1 MG) 100'S — accounts for $251.5K USD across 3 shipments. There are 76 distinct product descriptions in the dataset, reflecting the variety of dosage forms and strengths imported.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | REPAGLINIDE TABLETS 1 MG (REPAGLINIDE TABLETS USP 1 MG) 100'S | 3 | $251.5K | 7.3% |
| 2 | REPAGLINIDE TABLETS 2 MG REPAGLINIDE TABLETS USP 2 MG 100'S | 2 | $215.1K | 6.2% |
| 3 | REPAGLINIDE TABLETS 2 MG REPAGLINIDE TABLETS USP 2 MG 100 S 41880 X 100 S PACKS 4188000 NOS | 1 | $141.3K | 4.1% |
| 4 | REPAGLINIDE TABLETS 2MG (REPAGLINIDE TABLETS USP 2MG )100S QTY:41880 PACKS@RATEUSD.3.430NOS | 3 | $133.8K | 3.9% |
| 5 | REPAGLINIDE TABLETS 2 MG (REPAGLINIDE TABLETS USP 2 MG) 100'S | 6 | $132.1K | 3.8% |
| 6 | REPAGLINIDE TABLETS 2 MG (REPAGLINIDE TABLETS USP 2 MG) 100S | 3 | $124.7K | 3.6% |
| 7 | REPAGLINIDE TABLETS 0.5 MG REPAGLINIDETABLETS USP 0.5 MG 100'S | 3 | $95.8K | 2.8% |
| 8 | REPAGLINIDE TABLETS 1 MG REPAGLINIDE TABLETS USP 1 MG REPAGLINIDE TABLETS USP1 MG 100'S | 1 | $91.8K | 2.7% |
| 9 | REPAGLINIDE TABLETS USP 1 MG (31440 X 100'S PACK)NOS | 3 | $87.7K | 2.5% |
| 10 | REPAGLINIDE TABLETS 1 MG (Repaglinide Tablets USP 1 mg) (27840X100'S) | 1 | $80.3K | 2.3% |
Showing top 10 of 76 Repaglinide formulations imported by United States on this route.
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Sea freight dominates at 74%, typical for bulk pharmaceutical shipments.
Top Ports of Origin
HYDERABAD ICD handles the highest volume with 55 shipments. Transit time averages 15 days by sea.
Market Dynamics
India's repaglinide exports to United States are driven primarily by a handful of large-scale manufacturers. AUROBINDO PHARMA LTD with 76 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 3 active exporters signals a competitive but concentrated market — buyers in United States benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — AUROBINDO PHARMA LTD, AUROBINDO PHARMA LIMITED, MACLEODS PHARMACEUTICALS LTD — together account for 100% of total trade value on this route. The average shipment value of $27.4K USD reflects a mix of bulk commercial orders and smaller specialty shipments.
Beyond the primary product category, shipments on this route include closely related formulations such as repaglinide tablets 2 mg repaglinide tablets usp 2 mg 100's and repaglinide tablets 2 mg repaglinide tablets usp 2 mg 100 s 41880 x 100 s packs 4188000 nos, suggesting that buyers in United States tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, RISING PHARMA HOLDINGS INC is the largest importer with 16 shipments worth $463.1K USD — representing 13% of all repaglinide imports from India on this route. A total of 19 buyers are active on this corridor.
Route Statistics
- Trade Volume
- $3.5M
- Avg. Shipment
- $27.4K
- Suppliers
- 3
- Buyers
- 19
- Transit (Sea)
- ~15 days
- Annual Growth
- +17.6%
Related Analysis
Reverse Direction
United States → India — Repaglinide (Import)Other Repaglinide Routes
Unlock the Full India to United States Repaglinide Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 126 shipments on this route.
Frequently Asked Questions — India to United States Repaglinide Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Repaglinide to United States?
The leading Indian exporters of Repaglinide to United States are AUROBINDO PHARMA LTD, AUROBINDO PHARMA LIMITED, MACLEODS PHARMACEUTICALS LTD. AUROBINDO PHARMA LTD holds the largest market share at approximately 55% of total trade value on this route.
Q What is the total value of Repaglinide exports from India to United States?
India exports Repaglinide to United States worth approximately $3.5M USD across 126 recorded shipments. The average value per shipment is $27.4K USD.
Q Which ports does India use to ship Repaglinide to United States?
The most active port of origin is HYDERABAD ICD with 55 shipments. Indian exporters primarily use sea freight for this route, with 74% of shipments going by sea and 22% by air.
Q How long does shipping take from India to United States for Repaglinide?
The average transit time for Repaglinide shipments from India to United States is approximately 15 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during January–March.
Q Is the India to United States Repaglinide trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 17.6% with demand growth tracking at 17.0%. The route is ranked #8 among India's top Repaglinide export destinations globally.
Q How many suppliers are active on the India to United States Repaglinide route?
There are currently 3 active Indian suppliers exporting Repaglinide to United States. The market is moderately concentrated with AUROBINDO PHARMA LTD accounting for 55% of total shipment value.
Q Who are the main importers of Repaglinide from India in United States?
The leading importers of Indian Repaglinide in United States include RISING PHARMA HOLDINGS INC, AUROLOGISTICS LLC(AUROBINDO PHARMA, AUROLOGISTICS LLC AUROBINDO PHARM, AUROLOGISTICS LLC (AUROBINDO PHARMA, RISING PHARMA HOLDINGS, INC.. RISING PHARMA HOLDINGS INC is the largest buyer with 16 shipments worth $463.1K USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to United States export trade corridor identified from Indian Customs (DGFT) records for Repaglinide.
- 2.Supplier/Buyer Matching: 3 Indian exporters and 19 importers in United States matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 126 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
126 Verified Shipments
3 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists